NASDAQ:ILMN - Illumina Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $323.59
  • Forecasted Upside: 2.07 %
  • Number of Analysts: 17
  • Breakdown:
  • 3 Sell Ratings
  • 9 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$317.03
▲ +13.05 (4.29%)
1 month | 3 months | 12 months
Get New Illumina Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ILMN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ILMN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$323.59
▲ +2.07% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $323.59, with a high forecast of $400.00 and a low forecast of $280.00. The average price target represents a 2.07% upside from the last price of $317.03.
Hold
The current consensus among 17 polled investment analysts is to hold stock in Illumina. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 2 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 2 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 2 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 3 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 3 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 3 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 9 hold ratings
  • 3 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 9 hold ratings
  • 3 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 9 hold ratings
  • 3 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/30/2020SVB LeerinkBoost Price TargetOutperform$315.00 ➝ $325.00High
i
10/13/2020GuggenheimDowngradeBuy ➝ NeutralMedium
i
9/30/2020Atlantic SecuritiesInitiated CoverageOverweight$355.00 ➝ $355.00Medium
i
9/29/2020Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
i
9/22/2020Canaccord GenuityLower Price TargetHold$350.00 ➝ $300.00Low
i
9/22/2020Robert W. BairdLower Price TargetNeutral$335.00 ➝ $281.00Low
i
Rating by Catherine Ramsey Schulte at Robert W. Baird
9/22/2020SVB LeerinkLower Price TargetOutperform$360.00 ➝ $315.00Low
i
9/22/2020Stifel NicolausDowngradeBuy ➝ Hold$380.00 ➝ $280.00Low
i
9/22/2020UBS GroupDowngradeBuy ➝ Neutral$390.00 ➝ $285.00Low
i
9/21/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$390.00 ➝ $280.00Low
i
9/21/2020GuggenheimUpgradeNeutral ➝ Buy$345.00High
i
9/11/2020ArgusReiterated RatingBuy ➝ Reduce$380.00 ➝ $380.00Low
i
9/9/2020Morgan StanleyInitiated CoverageEqual Weight$400.00Low
i
8/7/2020SVB LeerinkLower Price TargetOutperform$370.00 ➝ $360.00High
i
8/7/2020Evercore ISIDowngradeIn-Line ➝ Underperform$310.00High
i
8/7/2020Piper SandlerDowngradeOverweight ➝ Neutral$356.00 ➝ $340.00High
i
7/7/2020GuggenheimDowngradeBuy ➝ NeutralLow
i
7/2/2020JPMorgan Chase & Co.Boost Price TargetOverweight$340.00 ➝ $390.00Low
i
5/21/2020ArgusBoost Price Target$340.00 ➝ $380.00Low
i
5/1/2020Piper SandlerLower Price TargetPositive ➝ Overweight$370.00 ➝ $356.00Low
i
5/1/2020Wells Fargo & CompanyBoost Price TargetUnderweight$245.00 ➝ $290.00Low
i
5/1/2020Stifel NicolausBoost Price TargetBuy$298.00 ➝ $325.00High
i
5/1/2020CowenBoost Price TargetOutperform$275.00 ➝ $320.00Medium
i
Rating by Doug Schenkel at Cowen Inc
4/24/2020CitigroupDowngradeBuy ➝ Neutral$250.00 ➝ $320.00Low
i
4/21/2020Robert W. BairdDowngradeOutperform ➝ Neutral$310.00High
i
4/15/2020Robert W. BairdLower Price TargetOutperform ➝ Outperform$339.00 ➝ $310.00Medium
i
4/2/2020Stifel NicolausLower Price TargetBuy$345.00 ➝ $298.00Medium
i
3/30/2020Wells Fargo & CompanyLower Price TargetUnderweight$290.00 ➝ $245.00Medium
i
3/26/2020BarclaysLower Price TargetOverweight$390.00 ➝ $350.00High
i
3/20/2020CitigroupLower Price TargetBuy$350.00 ➝ $250.00Low
i
2/4/2020Credit Suisse GroupReiterated RatingBuy$340.00Low
i
1/30/2020Wells Fargo & CompanyLower Price TargetUnderweight$300.00 ➝ $290.00Low
i
1/30/2020CitigroupLower Price TargetBuy$385.00 ➝ $350.00High
i
1/9/2020Piper SandlerBoost Price TargetOverweight$341.00 ➝ $370.00Low
i
1/7/2020Wells Fargo & CompanyInitiated CoverageUnderweight$300.00Medium
i
1/6/2020CitigroupInitiated CoverageBuy$385.00Low
i
1/3/2020UBS GroupUpgradeNeutral ➝ Buy$355.00Medium
i
12/18/2019CowenReiterated RatingOutperform$320.00 ➝ $335.00Medium
i
Rating by Doug Schenkel at Cowen Inc
11/14/2019Stifel NicolausInitiated CoverageBuy$345.00Medium
i
10/25/2019CowenSet Price TargetBuy$320.00Low
i
Rating by Doug Schenkel at Cowen Inc
10/25/2019Wolfe ResearchSet Price TargetBuy$380.00N/A
i
Rating by Steve Beuchaw at Wolfe Research
10/25/2019Piper Jaffray CompaniesLower Price TargetOverweight$348.00 ➝ $341.00High
i
Rating by William Quirk at Piper Jaffray Companies
10/25/2019GuggenheimInitiated CoverageBuy ➝ Buy$350.00 ➝ $350.00High
i
9/27/2019Piper Jaffray CompaniesSet Price TargetBuy$348.00Medium
i
Rating by William Quirk at Piper Jaffray Companies
9/25/2019ArgusBoost Price TargetBuy$300.00 ➝ $340.00Medium
i
7/31/2019Credit Suisse GroupReiterated RatingBuy$340.00Medium
i
7/30/2019UBS GroupBoost Price TargetBuy$350.00 ➝ $355.00Low
i
7/30/2019Piper Jaffray CompaniesLower Price TargetOverweight$382.00 ➝ $348.00Low
i
7/30/2019Canaccord GenuityDowngradeBuy ➝ Hold$330.00 ➝ $300.00Medium
i
7/18/2019ArgusLower Price TargetBuy$340.00Low
i
7/12/2019CowenLower Price TargetOutperform$380.00 ➝ $320.00Low
i
7/12/2019Canaccord GenuityLower Price TargetBuy$377.00 ➝ $330.00High
i
7/12/2019Deutsche Bank AktiengesellschaftLower Price TargetHold$290.00 ➝ $280.00High
i
7/12/2019Bank of AmericaDowngradeBuy ➝ Underperform$310.00High
i
6/10/2019Canaccord GenuityReiterated RatingBuy$350.00 ➝ $360.00Low
i
5/30/2019Wolfe ResearchInitiated CoverageOutperform ➝ OutperformLow
i
4/26/2019Canaccord GenuityReiterated RatingBuy$360.00 ➝ $350.00Medium
i
4/2/2019OTR GlobalDowngradePositiveLow
i
1/30/2019Bank of AmericaReiterated RatingBuy$355.00Low
i
1/30/2019SVB LeerinkUpgradeOutperform$380.00 ➝ $365.00High
i
1/25/2019Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$296.53Medium
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
1/7/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$320.00 ➝ $288.00Medium
i
1/3/2019UBS GroupUpgradeNeutral ➝ Buy$340.00 ➝ $370.00High
i
Rating by Daniel Brennan at UBS Group AG
10/24/2018BarclaysBoost Price TargetOverweight ➝ Overweight$350.00 ➝ $370.00High
i
10/12/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy$350.00Low
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
10/9/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$340.00Low
i
10/2/2018Piper Jaffray CompaniesBoost Price TargetOverweight$380.00Medium
i
9/6/2018CowenBoost Price TargetOutperform ➝ Positive$315.00 ➝ $400.00Low
i
8/10/2018ArgusSet Price TargetBuy ➝ Buy$310.00 ➝ $372.00Medium
i
Rating by Jasper Hellweg at Argus
8/7/2018Morgan StanleyUpgradeUnderweight ➝ Equal Weight$210.00 ➝ $320.00Low
i
7/31/2018JPMorgan Chase & Co.Boost Price TargetOverweight$350.00Medium
i
7/31/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$345.00 ➝ $370.00High
i
Rating by Derik De Bruin at Bank of America Co.
7/31/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$280.00 ➝ $330.00High
i
7/31/2018CitigroupBoost Price TargetBuy ➝ Buy$330.00 ➝ $345.00High
i
7/31/2018BarclaysBoost Price TargetOverweight ➝ Overweight$300.00 ➝ $350.00High
i
7/31/2018Piper Jaffray CompaniesReiterated RatingPositive ➝ Overweight$350.00High
i
7/27/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$330.00 ➝ $340.00High
i
7/17/2018Piper Jaffray CompaniesBoost Price TargetOverweight ➝ Overweight$272.00 ➝ $329.00Low
i
7/13/2018Morgan StanleyBoost Price TargetUnderweight$195.00 ➝ $210.00Medium
i
7/10/2018CowenBoost Price TargetOutperform ➝ Outperform$275.00 ➝ $315.00High
i
6/25/2018CitigroupBoost Price TargetBuy ➝ Buy$275.00 ➝ $330.00High
i
5/31/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$180.00 ➝ $195.00Low
i
5/29/2018Canaccord GenuityBoost Price TargetBuy ➝ Top Pick$270.00 ➝ $290.00Low
i
5/7/2018BarclaysUpgradeEqual Weight ➝ Overweight$235.00High
i
4/25/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$215.00 ➝ $235.00Medium
i
4/25/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$170.00 ➝ $180.00Medium
i
4/25/2018BTIG ResearchReiterated RatingHoldHigh
i
Rating by Sung Ji Nam at BTIG Research
4/25/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$261.00 ➝ $271.00High
i
4/11/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$157.00 ➝ $170.00Low
i
2/5/2018CitigroupUpgradeNeutral ➝ Buy$260.00 ➝ $275.00High
i
1/31/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$200.00 ➝ $215.00Medium
i
1/31/2018CitigroupReiterated RatingHold$260.00Medium
i
1/31/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$145.00 ➝ $157.00High
i
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$250.00 ➝ $276.00High
i
1/31/2018Canaccord GenuityReiterated RatingBuy$255.00 ➝ $265.00High
i
1/31/2018First AnalysisUpgradeEqual Weight ➝ Overweight$277.00High
i
1/22/2018CowenBoost Price TargetOutperform$250.00 ➝ $275.00Low
i
1/16/2018BTIG ResearchReiterated RatingHoldLow
i
Rating by Sung Ji Nam at BTIG Research
1/16/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$275.00Medium
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
1/9/2018Wells Fargo & CompanyReiterated RatingOutperform ➝ Positive$250.00 ➝ $260.00High
i
1/9/2018Piper Jaffray CompaniesReiterated RatingBuy$269.00N/A
i
1/5/2018William BlairDowngradeOutperform ➝ Market PerformMedium
i
Rating by A. Murphy at William Blair
1/5/2018BTIG ResearchInitiated CoverageNeutral ➝ NeutralHigh
i
Rating by Sung Ji Nam at BTIG Research
1/4/2018Piper Jaffray CompaniesBoost Price TargetOverweight$274.00Medium
i
1/3/2018Evercore ISIInitiated CoverageOutperform$250.00Low
i
1/2/2018Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$205.00Medium
i
12/14/2017Morgan StanleyBoost Price TargetUnderweight$122.00 ➝ $135.00Medium
i
10/25/2017CitigroupBoost Price TargetNeutral$180.00 ➝ $220.00N/A
i
10/25/2017BarclaysBoost Price TargetEqual Weight$150.00 ➝ $185.00N/A
i
10/25/2017Bank of AmericaBoost Price TargetBuy$215.00 ➝ $240.00N/A
i
10/25/2017Wells Fargo & CompanyReiterated RatingMarket Perform$200.00 ➝ $205.00N/A
i
10/25/2017Robert W. BairdUpgradeNeutral ➝ Outperform$184.00 ➝ $228.00N/A
i
10/23/2017Janney Montgomery ScottUpgradeSell ➝ NeutralN/A
i
10/23/2017Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$195.00 ➝ $160.00N/A
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
10/12/2017Canaccord GenuityReiterated RatingBuy$215.00 ➝ $230.00N/A
i
10/9/2017Piper Jaffray CompaniesReiterated RatingOverweight$202.00 ➝ $226.00N/A
i
9/26/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$200.00Low
i
9/13/2017ArgusBoost Price TargetBuy$205.00 ➝ $235.00Low
i
9/12/2017SVB LeerinkReiterated RatingOutperform$207.00 ➝ $225.00Low
i
Rating by Puneet Souda at SVB Leerink LLC
8/9/2017BarclaysReiterated RatingEqual Weight$150.00Low
i
8/7/2017Canaccord GenuityUpgradeHold ➝ Buy$170.00 ➝ $215.00Medium
i
8/2/2017CowenReiterated RatingOutperform$200.00High
i
8/2/2017JPMorgan Chase & Co.Reiterated RatingOverweight$250.00High
i
8/2/2017First AnalysisUpgradeUnderweight ➝ Equal Weight$176.00High
i
Rating by Joseph Munda at First Analysis
7/28/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$175.00Low
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
7/26/2017Canaccord GenuityReiterated RatingHold$170.00Medium
i
7/19/2017BarclaysReiterated RatingHold$150.00Low
i
7/10/2017Morgan StanleyReiterated RatingUnderweight$115.00 ➝ $122.00High
i
5/15/2017Morgan StanleyReiterated RatingUnderweight$108.00 ➝ $115.00Medium
i
4/29/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$165.00 ➝ $175.00Low
i
4/26/2017CowenReiterated RatingOutperform$200.00High
i
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$155.00 ➝ $170.00High
i
4/14/2017Piper Jaffray CompaniesReiterated RatingOverweight$170.00 ➝ $187.00N/A
i
4/11/2017Bank of AmericaBoost Price TargetBuy$175.00 ➝ $195.00Low
i
4/5/2017SVB LeerinkReiterated RatingBuyMedium
i
Rating by Puneet Souda at SVB Leerink LLC
3/20/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$195.00Medium
i
Rating by P. Souda at SVB Leerink LLC
3/19/2017BTIG ResearchReiterated RatingHoldMedium
i
2/27/2017Evercore ISIUpgradeHold ➝ Buy$190.00N/A
i
2/21/2017Canaccord GenuityReiterated RatingHold$150.00N/A
i
Rating by Mark Massaro at Canaccord Genuity
2/9/2017SVB LeerinkBoost Price TargetMarket Perform$134.00 ➝ $138.00N/A
i
Rating by P. Souda at SVB Leerink LLC
2/1/2017UBS GroupBoost Price TargetBuy$180.00 ➝ $185.00N/A
i
2/1/2017Cantor FitzgeraldReiterated RatingNeutral$155.00N/A
i
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$160.00N/A
i
1/12/2017Cantor FitzgeraldReiterated RatingNeutral$155.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
1/12/2017Robert W. BairdReiterated RatingNeutral$147.00 ➝ $153.00N/A
i
1/11/2017CowenReiterated RatingOutperform$150.00N/A
i
1/11/2017SVB LeerinkReiterated RatingMarket Perform$114.00 ➝ $132.00N/A
i
Rating by P. Souda at SVB Leerink LLC
1/10/2017Evercore ISIReiterated RatingHold$139.00N/A
i
1/10/2017Bank of AmericaUpgradeNeutral ➝ Buy$145.00 ➝ $175.00N/A
i
1/9/2017BarclaysReiterated RatingEqual Weight$145.00N/A
i
Rating by Jack Meehan at Barclays PLC
1/6/2017Janney Montgomery ScottReiterated RatingNeutral ➝ Sell$125.00N/A
i
Rating by Paul Knight at Janney Montgomery Scott
1/6/2017CL KingUpgradeNeutral ➝ BuyN/A
i
12/7/2016Morgan StanleyLower Price TargetUnderweight$115.00 ➝ $100.00N/A
i
11/10/2016SVB LeerinkInitiated CoverageMarket Perform$145.00N/A
i
Rating by P. Souda at SVB Leerink LLC
11/3/2016Cantor FitzgeraldReiterated RatingHold$155.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
11/3/2016BTIG ResearchReiterated RatingHoldN/A
i
11/2/2016Canaccord GenuitySet Price TargetHold$135.00N/A
i
Rating by Mark Massaro at Canaccord Genuity
11/2/2016First AnalysisDowngradeEqual Weight ➝ Underweight$130.00 ➝ $116.00N/A
i
10/14/2016ArgusReiterated RatingBuy$205.00 ➝ $170.00N/A
i
10/12/2016CowenReiterated RatingOutperform$160.00N/A
i
Rating by Doug Schenkel at Cowen Inc
10/12/2016Wells Fargo & CompanyReiterated RatingMarket Perform$150.00 ➝ $137.50N/A
i
10/12/2016BTIG ResearchReiterated RatingNeutralN/A
i
Rating by Dane Leone at BTIG Research
10/11/2016Canaccord GenuityLower Price TargetHold$165.00 ➝ $135.00N/A
i
Rating by Mark Massaro at Canaccord Genuity
10/11/2016BarclaysSet Price TargetEqual Weight$150.00 ➝ $142.00N/A
i
10/11/2016Cantor FitzgeraldLower Price TargetHold$165.00 ➝ $155.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
10/11/2016Janney Montgomery ScottDowngradeNeutral ➝ Sell$155.00 ➝ $125.00N/A
i
10/11/2016CitigroupDowngradeBuy ➝ Neutral$190.00 ➝ $140.00N/A
i
Rating by Daniel Arias at Citigroup Inc.
10/7/2016Canaccord GenuitySet Price TargetHold$165.00 ➝ $136.00N/A
i
Rating by Mark Massaro at Canaccord Genuity
9/12/2016CitigroupBoost Price TargetBuy$175.00 ➝ $190.00N/A
i
Rating by Daniel Arias at Citigroup Inc.
8/22/2016CL KingDowngradeBuy ➝ NeutralN/A
i
8/16/2016UBS GroupReiterated RatingBuyN/A
i
Rating by Jon Groberg at UBS Group AG
8/8/2016ArgusBoost Price TargetBuy$175.00 ➝ $185.00N/A
i
Rating by John Eade at Argus
7/28/2016UBS GroupReiterated RatingBuy$180.00N/A
i
Rating by Jon Groberg at UBS Group AG
7/27/2016JPMorgan Chase & Co.Boost Price TargetOverweight$185.00 ➝ $200.00N/A
i
7/27/2016Cantor FitzgeraldReiterated RatingHold$165.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
7/27/2016MizuhoBoost Price TargetNeutral$138.00 ➝ $148.00N/A
i
Rating by Eric Criscuolo at Mizuho
7/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$161.00N/A
i
Rating by William Quirk at Piper Jaffray Companies
7/5/2016Morgan StanleyDowngradeEqual Weight ➝ Underweight$130.00 ➝ $110.00N/A
i
Rating by Steve Beuchaw at Morgan Stanley
6/29/2016Cantor FitzgeraldReiterated RatingHoldN/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
6/21/2016CL KingInitiated CoverageBuy$165.00N/A
i
6/4/2016Canaccord GenuityReiterated RatingHoldN/A
i
Rating by Mark Massaro at Canaccord Genuity
6/2/2016Cantor FitzgeraldReiterated RatingHold$165.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
5/4/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Dan Leonard at SVB Leerink LLC
5/4/2016Cantor FitzgeraldReiterated RatingHold$165.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
5/4/2016Canaccord GenuityReiterated RatingHold$160.00 ➝ $140.00N/A
i
Rating by Mark Massaro at Canaccord Genuity
5/4/2016Stifel NicolausReiterated RatingBuy$215.00 ➝ $160.00N/A
i
Rating by Miroslava Minkova at Stifel Nicolaus
5/4/2016CitigroupReiterated RatingBuy$210.00 ➝ $175.00N/A
i
5/4/2016MizuhoReiterated RatingNeutral$150.00 ➝ $138.00N/A
i
Rating by Eric Criscuolo at Mizuho
5/3/2016Nomura SecuritiesLower Price TargetBuy$210.00 ➝ $180.00N/A
i
5/3/2016UBS GroupLower Price TargetBuy$210.00 ➝ $180.00N/A
i
Rating by Jon Groberg at UBS Group AG
5/3/2016Morgan StanleyLower Price TargetEqual Weight$140.00 ➝ $130.00N/A
i
Rating by Steve Beuchaw at Morgan Stanley
4/22/2016Avondale PartnersReiterated RatingMarket Perform$175.00 ➝ $160.00N/A
i
4/22/2016CitigroupReiterated RatingBuy$210.00N/A
i
4/19/2016BTIG ResearchReiterated RatingHoldN/A
i
Rating by Dane Leone at BTIG Research
4/19/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
i
Rating by William Quirk at Piper Jaffray Companies
4/19/2016Robert W. BairdReiterated RatingHoldN/A
i
Rating by Jeff Elliott at Robert W. Baird
4/19/2016MizuhoReiterated RatingNeutral$150.00N/A
i
4/19/2016SVB LeerinkReiterated RatingMarket Perform$175.00 ➝ $165.00N/A
i
4/19/2016CowenReiterated RatingOutperform$215.00 ➝ $180.00N/A
i
4/19/2016Cantor FitzgeraldDowngradeBuy ➝ Hold$225.00 ➝ $165.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
4/19/2016Bank of AmericaDowngradeBuy ➝ NeutralN/A
i
4/19/2016Morgan StanleyReiterated RatingEqual Weight$160.00 ➝ $140.00N/A
i
4/19/2016BarclaysLower Price TargetEqual Weight$175.00 ➝ $160.00N/A
i
4/18/2016Canaccord GenuityReiterated RatingHoldN/A
i
Rating by Mark Massaro at Canaccord Genuity
4/18/2016UBS GroupReiterated RatingBuy$210.00N/A
i
Rating by Jon Groberg at UBS Group AG
4/11/2016Piper Jaffray CompaniesReiterated RatingBuy$204.00N/A
i
Rating by William Quirk at Piper Jaffray Companies
3/30/2016ArgusInitiated CoverageBuy$175.00N/A
i
3/23/2016The Goldman Sachs GroupLower Price Target$141.00N/A
i
3/9/2016Canaccord GenuityReiterated RatingHold$160.00N/A
i
Rating by Mark Massaro at Canaccord Genuity
3/8/2016BTIG ResearchReiterated RatingHoldN/A
i
Rating by Dane Leone at BTIG Research
2/4/2016Canaccord GenuityDowngradeBuy ➝ Hold$205.00 ➝ $160.00N/A
i
Rating by Mark Massaro at Canaccord Genuity
2/3/2016Robert W. BairdLower Price TargetNeutral$180.00 ➝ $175.00N/A
i
2/3/2016Deutsche Bank AktiengesellschaftReiterated RatingHold$178.00 ➝ $160.00N/A
i
Rating by Shawn Bevec at Deutsche Bank Aktiengesellschaft
2/3/2016BTIG ResearchReiterated RatingNeutralN/A
i
Rating by Dane Leone at BTIG Research
2/3/2016Evercore ISILower Price TargetHold$177.00 ➝ $160.00N/A
i
2/3/2016Piper Jaffray CompaniesUpgradeBuy$219.00 ➝ $215.00N/A
i
Rating by William Quirk at Piper Jaffray Companies
2/3/2016Cantor FitzgeraldReiterated RatingBuy$225.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
1/19/2016Piper Jaffray CompaniesReiterated RatingOverweight$219.00N/A
i
Rating by William Quirk at Piper Jaffray Companies
1/13/2016MizuhoReiterated RatingNeutral$150.00N/A
i
Rating by Eric Criscuoloare at Mizuho
1/13/2016BTIG ResearchReiterated RatingNeutralN/A
i
Rating by Dane Leone at BTIG Research
1/11/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
i
Rating by William Quirk at Piper Jaffray Companies
1/11/2016Canaccord GenuityReiterated RatingBuy$205.00N/A
i
Rating by Mark Massaro at Canaccord Genuity
1/7/2016CowenBoost Price Target$215.00N/A
i
Rating by Doug Schenkel at Cowen Inc
1/7/2016BarclaysBoost Price TargetEqual Weight$170.00 ➝ $175.00N/A
i
1/7/2016Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
i
1/6/2016Avondale PartnersInitiated CoverageMarket Perform$175.00N/A
i
1/6/2016Deutsche Bank AktiengesellschaftInitiated CoverageHold$192.00N/A
i
1/5/2016Piper Jaffray CompaniesReiterated RatingOverweight$219.00N/A
i
Rating by William Quirk at Piper Jaffray Companies
12/21/2015Stifel NicolausBoost Price TargetBuy$175.00 ➝ $215.00N/A
i
Rating by Miroslava Minkova at Stifel Nicolaus
(Data available from 11/28/2015 forward)
Illumina logo
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $317.03
$304.01
$319.33

50 Day Range

MA: $313.30
$292.70
$352.32

52 Week Range

Now: $317.03
$196.78
$404.20

Volume

981,027 shs

Average Volume

1,277,199 shs

Market Capitalization

$46.29 billion

P/E Ratio

73.56

Dividend Yield

N/A

Beta

1.1